Medical Device CI/CD: Speed and Compliance
Discover how CI/CD pipelines revolutionize medical device development by accelerating innovation while ensuring strict adherence to FDA, ISO, and HIPAA.
Clinical research notes, regulatory guidance, and engineering deep dives from the NexaMedTech team.
We publish practitioner notes from clinical engineers and regulatory scientists working on real diagnostics, biosensors, and connected care. Expect plain-language explainers, checklists you can use tomorrow, and deep dives that respect nuance.
Popular themes include ISO 14971 risk thinking, 10993 biological evaluation, SaMD evidence and model validation, manufacturability at small scale, and the unglamorous plumbing that keeps PHI safe.
We publish practical notes for teams building diagnostics, wearable biosensors, and AI‑health systems. Each article is written by clinical engineers who ship regulated software and devices, with enough detail that a reviewer can reproduce the claims. We focus on methods, data provenance, and the trade‑offs behind design choices rather than hype cycles.
Topics span study design and validation, interoperability, privacy and compliance, and manufacturability for connected care. When AI models appear, we discuss how to benchmark them against classical baselines and how to present results a clinical reviewer can audit. Our goal is a shared playbook the field can reuse.
If you want us to cover a specific question, or you are working through a tricky regulatory or engineering decision, contact our team. We are happy to help.
34 articles · page 2 of 2
Discover how CI/CD pipelines revolutionize medical device development by accelerating innovation while ensuring strict adherence to FDA, ISO, and HIPAA.
Implement secure CI/CD for SaaS medical devices in 2026. Learn best practices for FDA 21 CFR 820, ISO 13485, HIPAA, and IEC 62304 compliance.
Continuous biosensing generates enormous volumes of data and very little clinical value unless the signal survives daily life. Here is what held up.
Retrospective AUC is the beginning of the conversation, not the end. A practical validation sequence for models that will touch patients.
A chip that works at 20 units and fails at 20,000 is a common and expensive outcome. Design decisions that survive scale-up.
Device data that cannot reach the record is invisible. An interoperability pattern that has survived multiple health-system rollouts.
The pathway you choose shapes your architecture, your evidence plan, and your release cadence. Decide it early and deliberately.
Explore how Agentic AI transforms MedTech QMS, automating compliance with FDA 21 CFR Part 820, ISO 13485, and HIPAA. Reduce burden for QA professionals.
By 2027, agentic AI will redefine medical device software validation, offering unprecedented efficiency, compliance, and accuracy for CTOs and QA managers.
Leverage AI agents for real-time medical device post-market surveillance. Understand FDA, ISO, and HIPAA compliance in 2026 with NexaMedTech.